|
|
|
Content :
Guide to Vermont's pharmaceutical marketer price disclosure law
This information is intended for U.S. residents.
| Product Name | Short Form | Long Form | Date updated |
|---|
| Allegra | | | 02-01-2011 |
|---|
| Ambien | | | 2-01-2013 |
|---|
| Anzemet | | | 2-01-2013 |
|---|
| Aplenzin | | | 2-01-2013 |
|---|
| Avapro | | - | 09-01-2011 |
|---|
| Avalide | | - | 09-01-2011 |
|---|
| DDAVP | | | 02-01-2011 |
|---|
| Ketek | | | 2-01-2013 |
|---|
| Multaq | | | 2-01-2013 |
|---|
| Oforta | | | 02-01-2011 |
|---|
| Plavix | | - | 09-01-2011 |
|---|
| Rilutek | | | 2-01-2013 |
|---|
| Uroxatral | | | 2-01-2013 |
|---|
| Xyzal | | | 2-01-2013 |
|---|
|
Modules :
|
|